The document discusses a new drug called Peridose that was created by Anthropic to treat symptoms of Alzheimer's disease. The drug targets amyloid beta proteins in the brain that are associated with Alzheimer's. Anthropic has submitted Peridose to the FDA for approval and hopes it will be a breakthrough in treating the symptoms of this disease if approved.